P2RY1
P2RY1 is a gene that encodes the protein P2Y1 receptor, which is a member of the P2Y receptor family. This family of receptors is part of the larger group of G protein-coupled receptors (GPCRs) that are activated by extracellular nucleotides such as adenosine triphosphate (ATP) and adenosine diphosphate (ADP).
Function[edit | edit source]
The P2Y1 receptor is primarily involved in the regulation of platelet aggregation and thrombosis. Upon activation by ADP, the P2Y1 receptor initiates a signaling cascade that leads to the activation of phospholipase C, resulting in the production of inositol trisphosphate (IP3) and the release of intracellular calcium ions (Ca2+). This process is crucial for the amplification of platelet activation and the formation of a stable platelet plug during the process of hemostasis.
Expression[edit | edit source]
P2RY1 is expressed in various tissues, with significant expression in platelets, the central nervous system, and the vascular endothelium. The receptor plays a role in various physiological processes, including vascular tone regulation, neurotransmission, and immune response.
Clinical Significance[edit | edit source]
Mutations or dysregulation of the P2RY1 gene can lead to various pathological conditions. For instance, altered P2Y1 receptor function has been implicated in bleeding disorders and thrombotic diseases. Additionally, the receptor is a potential therapeutic target for the treatment of cardiovascular diseases, neurological disorders, and inflammatory conditions.
Related Receptors[edit | edit source]
The P2Y receptor family includes several other receptors such as P2Y2 receptor, P2Y4 receptor, P2Y6 receptor, and P2Y12 receptor. Each of these receptors has distinct ligand specificities and physiological roles.
See Also[edit | edit source]
- G protein-coupled receptor
- Platelet aggregation
- Thrombosis
- Hemostasis
- Phospholipase C
- Inositol trisphosphate
- Calcium signaling
- Vascular endothelium
- Cardiovascular diseases
- Neurological disorders
- Inflammatory conditions
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
